SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001854270-23-000074
Filing Date
2023-06-21
Accepted
2023-06-21 19:12:04
Documents
1
Period of Report
2023-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1687389110.html 4  
1 FORM 4 wk-form4_1687389110.xml 4 3958
  Complete submission text file 0001854270-23-000074.txt   5601
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Issuer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SENTI BIOSCIENCES, INC. 2 CORPORATE DRIVE FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
COOPERSTONE BRENDA (Reporting) CIK: 0001931514 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40440 | Film No.: 231031184